Evokai Creative Labs, Inc. (OKAI.H.V)
0.115
0.00 (0.00%)
CAD |
TSXV |
Oct 02, 16:00
Evokai Creative Labs Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.642M |
| October 01, 2026 | 1.642M |
| September 30, 2026 | 1.642M |
| September 29, 2026 | 1.642M |
| September 28, 2026 | 1.642M |
| September 25, 2026 | 1.642M |
| September 24, 2026 | 1.642M |
| September 23, 2026 | 1.642M |
| September 22, 2026 | 1.642M |
| September 21, 2026 | 1.642M |
| September 18, 2026 | 1.642M |
| September 17, 2026 | 1.642M |
| September 16, 2026 | 1.642M |
| September 15, 2026 | 1.642M |
| September 14, 2026 | 1.642M |
| September 11, 2026 | 1.642M |
| September 10, 2026 | 1.642M |
| September 09, 2026 | 1.642M |
| September 08, 2026 | 1.642M |
| September 04, 2026 | 1.642M |
| September 03, 2026 | 1.642M |
| September 02, 2026 | 1.642M |
| September 01, 2026 | 1.642M |
| August 31, 2026 | 1.642M |
| August 28, 2026 | 1.642M |
| Date | Value |
|---|---|
| August 27, 2026 | 1.642M |
| August 26, 2026 | 1.642M |
| August 25, 2026 | 1.642M |
| August 24, 2026 | 1.642M |
| August 21, 2026 | 1.642M |
| August 20, 2026 | 1.642M |
| August 19, 2026 | 1.642M |
| August 18, 2026 | 1.642M |
| August 17, 2026 | 1.642M |
| August 14, 2026 | 1.642M |
| August 13, 2026 | 1.642M |
| August 12, 2026 | 1.642M |
| August 11, 2026 | 1.642M |
| August 10, 2026 | 1.642M |
| August 07, 2026 | 1.642M |
| August 06, 2026 | 1.642M |
| August 05, 2026 | 1.642M |
| August 04, 2026 | 1.642M |
| July 31, 2026 | 1.642M |
| July 30, 2026 | 1.642M |
| July 29, 2026 | 1.642M |
| July 28, 2026 | 1.642M |
| July 27, 2026 | 1.642M |
| July 24, 2026 | 1.642M |
| July 23, 2026 | 1.642M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Diagnos, Inc. | 44.03M |
| Arch Biopartners, Inc. | 61.83M |
| Avricore Health, Inc. | 5.396M |
| Kane Biotech, Inc. | 7.260M |
| CardioComm Solutions, Inc. | -- |